SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0000950135-05-002947
Filing Date
2005-05-19
Accepted
2005-05-18 21:53:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b55155ttprem14a.htm PREM14A 1171782
3 GRAPHIC b55155ttb5515506.gif GRAPHIC 808
4 GRAPHIC b55155ttb5515500.gif GRAPHIC 1655
5 GRAPHIC b55155ttb5515504.gif GRAPHIC 1425
6 GRAPHIC b55155ttb5515503.gif GRAPHIC 1464
7 GRAPHIC b55155ttb5515505.gif GRAPHIC 2997
  Complete submission text file 0000950135-05-002947.txt   1185328
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 000-21481 | Film No.: 05843179
SIC: 2836 Biological Products, (No Diagnostic Substances)